trending Market Intelligence /marketintelligence/en/news-insights/trending/z26ZlBrF31CWcbbr_qZsiQ2 content esgSubNav
In This List

Epizyme CFO to step down

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Epizyme CFO to step down

Epizyme Inc. said Andrew Singer will step down as CFO and executive vice president of finance and administration at the end of August to pursue other business opportunities.

Susan Graf, chief business officer, will take over the responsibility for the finance organization going forward, including Epizyme's financial reporting and analysis group.

Epizyme plans to add a senior vice president of finance beginning in September and has secured the professional finance consulting services of Danforth Advisors during this transition.